FDA Approves Opdivo for Post-Surgical Stage 2B or 2C Melanoma
The FDA approved Opdivo for the treatment of patients aged 12 years and older with stage 2B or 2C melanoma that has been surgically removed
Source: curetoday.com
Page 4 - Melanoma Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Melanoma Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Melanoma Program Today - Breaking & Trending Today
Dr Sullivan on the Reduction of ctDNA With Tebentafusp in Metastatic Uveal Melanoma
Ryan J. Sullivan, MD, discusses the early reduction of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp and shares how these reductions could correlate with longer overall survival in patients with a best response of stable disease.
Source: onclive.com
Dr Hamid on the Investigation of Fianlimab With Cemiplimab in Advanced Melanoma
Omid Hamid, MD, discusses the investigation of the LAG-3 inhibitor fianlimab in combination with cemiplimab in patients with advanced melanoma who were naïve to anti–PD-1 agents in the advanced setting.
Source: onclive.com
New hope for melanoma patients: Promising one-two punch can extend life expectancy
Researchers are making big gains in fighting melanoma.
Source: abc7.com
Staying Safe in the Sun: Spot the Warning Signs of Skin Cancer
While the great outdoors offers countless health benefits and lots of fun, it’s important to prioritize sun care.
Source: nbcconnecticut.com